Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CD20-directed Antibody Interactions [MoA]: Side Effects & Safety Data for 7 Drugs

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CD20-directed Antibody Interactions [MoA] includes 7 drugs with a combined 283,641 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.

7
Drugs in Class
283,641
Combined Reports

All CD20-directed Antibody Interactions [MoA] Drugs Ranked by Reports

Drug Brand Name Reports Deaths Hosp. Death Rate
RITUXIMAB Rituxan 178,614 28,910 54,631 16.2%
OCRELIZUMAB OCREVUS 56,186 1,406 10,364 2.5%
OFATUMUMAB ARZERRA 29,913 695 3,616 2.3%
OBINUTUZUMAB Gazyva 14,189 1,919 5,419 13.5%
EPCORITAMAB EPKINLY 2,041 430 1,652 21.1%
UBLITUXIMAB BRIUMVI 1,582 27 213 1.7%
GLOFITAMAB Columvi 1,116 315 492 28.2%

Common Side Effects in CD20-directed Antibody Interactions [MoA] Drugs

Side EffectReportsDeaths
Off label use 44,101 6,633
Drug ineffective 35,774 3,273
Fatigue 26,962 2,543
Pain 22,581 2,151
Covid-19 20,358 2,159
Rheumatoid arthritis 19,922 2,167
Headache 16,435 1,921
Pyrexia 16,412 2,295
Infusion related reaction 15,416 2,306
Pneumonia 14,917 3,522
View detailed side effects for this class → Compare drugs in this class →